æééå®ïŒãã£ã³ããŒã³ã»News
âïž5æãåŸãªã³ã¹ã¡ã¯ïŒâïžâïž
èæŽ»ã ãã¯ãã¡ãã®ããã¯ãšãããµãŒãžâšãšé·å¹Žæçšã®æ¹ãå€ãã³ã¹ã¡âª
也ç¥ç¥ããã«âšâš
ãèã¯ãã¡ã现ããéææããµããµãããã¡ãã¡è¶èãå°é¡ã«âšâš
ã¯ã¬ã€ããã¯â¶ïž4,180åãã
ãããµãŒãžãžã§ã«â¶ïž3,300å
âïžã¯ã¬ã€ããã¯ã®ã¿è³Œå ¥
â¶ïž10%OFF
âïžã¢ã¯ã¢ãœãããããµãŒãžãžã§ã«ã®ã¿è³Œå ¥â¶ïž 10%OFF
âïžãã¯ã¬ã€ããã¯ïŒãããµãŒãžãã»ããã§ã20%OFF âšâš7,480åâ¶ïž 5,984å
â æµããŠã¹ãããªãã€ãèã»ã«ãã§ã¹ã
ãã¯ã¿ãŒãã«ãã®ã¢ã¯ã¢ãœãããããµãŒãžãžã§ã«ã¯ãææèã®æ¹ã䜿ããäœåºæ¿ã®ããããèšèšããªããããªæãã¹ãã®ãžã§ã«ã§ãèã«è² æ ãããã广çã«ãããµãŒãžãè¡ãããšãã§ããŸãã
ãžã§ã«ã«å«ãŸãããã¢ã«ãã³é žãããããªã€ã«ããããããšãã€ãäžããã¯ãªãµã³ãã«ã ã€ã³ãžã¯ã ãšãã¹ïŒãŽãŒã«ãã³ã«ã¢ããŒã«ïŒããã§ãŠãžãšãã¹ïŒã¯ããŒãïŒãã¯ãã¢ããã±ã€ãœãŠæå®ãšãã¹ïŒããã·ã§ã³ãã«ãŒãïŒãªã©ã®åçš®æ€ç©ãšãã¹ãèãåŒãç· ããããªåŒŸåã¢ããããµããŒãããŸãã
å¯ãã§ããã°ããã©ãããããã¿ãã¡ãªå¬ã®èããå·¡ãããµããŒããããããµãŒãžã®å¹æã§ãã£ãããããããšããè¡è²
èã«æŽããç¶ããããšã§ãåŒãç· ãŸã£ãçŸèã«ã
â èªåã®æã§è§ŠããªããããããèãšåãåããããµãŒãžã
ãã¹ã¿ã€ã ã«1ïœ2åã®ã»ã«ããšã¹ããæ°å¹Žã®è掻ã«å ããŠã¿ãŸããã
#ãã¯ã¿ãŒãã«ã
#ãã¯ã¿ãŒãã«ãåç²§å
#arbaeltz
#ã¯ã¬ã€ããã¯
ïŒæ¯ç©Žã®é»ãã¿ã±ã¢
#æŽãæµãããã¯
#ãªãã¡ã€ãã³ã°ã¯ã¬ã€ããã¯
ïŒãããµãŒãžã¯ãªãŒã
ïŒãããµãŒãžãžã§ã«
ïŒçŸèãããµãŒãž
ïŒã¢ã¯ã¢ãœãããããµãŒãžãžã§ã«
ã玹ä»ããã ããŸããâª
ãã¯ã¿ãŒãã«ãã¯ä»å¹Žã§åµæ¥ïŒïŒå¹Žç®ããªãã¡ã€ãã³ã° ã¯ã¬ã€ããã¯ãäœåºŠãæ¹è¯ãéããå€ãã®çæ§ã«ãæé¡§ããã ããŠãããã³ã°ã»ã©ãŒååã§ãã ãããŸã§ã«å€ãã®çŸå®¹å®¶ã®çæ§ã«ã䜿ãããã ããããŸããŸãªéèªåªäœã»ã¡ãã£ã¢ã«ãŠã玹ä»ããã ããŸãããïŒæ²èŒèšäºã¯æ¹è¯åã®ã¯ã¬ã€ããã¯ã«ãªããŸãïŒ
ããã¯ããããµãŒãžãžã§ã«ã£ãŠ
䜿ããšã©ããªå¹æïŒïŒïŒïŒ
æ¯ç©Žæ±ãããŽã¯ãŽã¯è§è³ªããã¿ãã¿ç®èãã¯ãªã¢ã«é«ãåžçåïŒããã©ã«è±å¯ãª3çš®ã®ã¯ã¬ã€é å
ãèããŽã¯ãŽã¯ããŠã¡ã€ã¯ã®ããæªããã錻ã®ã¶ã©ã€ããé»ãã¿ãæ°ã«ãªãã…ã ããã¯èã®ãµã€ã¯ã«ãåæ»ããŠå€ãè§è³ªãæºãŸãã也ç¥ããŠããŸã£ãŠãããããããããŸããã èããããã§ããªãç¡ããªããããæ¯ç©Žãç®ç«ã¡ãæ±ããæºãŸãããããªããŸãã æŽãæµãã¯ã¬ã€ããã¯ã§ããŽã¯ãŽã¯ãæ¯ç©Žæ±ããã€ãããšæŽãæµããŠãéææã®ãããªãããçŽ èãæã«å ¥ããŸãããïŒ
âã¯ã¬ã€ã®åªããåžçåïŒ
ã¯ã¬ã€ã®äžçªã®æ©èœã¯ããªããšãã£ãŠããã®åžçåãèµ€è¡çããå°ããªç²åãæ®éã®æŽé¡ã§ã¯åãé€ããªãå€ãè§è³ªãæ¯ç©Žã®æ±ããäœåãªç®èããã ããã«åãé€ããèãå¥ãããªç¶æ ã«æŽããŸãã
äœåãªãã®ãåãé€ããèã¯éææã«ããµããåç²§æ°Žãªã©ã浞éããããç¶æ ã«ãã¡ã€ã¯ã®ããè¯ããªããŸãã


ãªãã¡ã€ãã³ã° ã¯ã¬ã€ããã¯ã«ã¯ããããªã³ã·ã«ãïŒã¯ãã£ïŒã ãã¿ãã¯ã©ã¯ã¬ã€ïŒãããã¯ãã³ïŒããšåžçåã®é«ããã«ãªãªã³ãã®ïŒçš®ã®å€©ç¶ã¯ã¬ã€ãé åã
ããªã³ã·ã«ããšãããã¯ãã³ã¯æ°åäžå¹Žã«ããããæµ·åºã«å ç©ããæµ·æ³¥ããå°ç€ã®éèµ·ã§å°è¡šã«çŸãããã®ãæµ·æŽæ§åæ€ç©ïŒæµ·è»é¡ããã©ã³ã¯ãã³ãªã©ïŒãã埮çç©ã«ãã£ãŠåè§£ãããããã©ã«ãè±å¯ã«å«ãã§ããŸãã
ã¯ã¬ã€ãæ±ããåžçããäžæ¹ã§ãããã©ã«ã溶ãåºããŠèã«æµžéããã£ãšããªããããªèã«å°ããŸãã
âããããã·ã¢ãã¿ã€ããã·ãªã«ããèèããå¹ãåºç©ã®åå ç©è³ªãåžçããæŽã«ã¯ãªã¢ãªèãž
ããããã·ã¢ãã¿ã€ãã¯ãªã³é
žã«ã«ã·ãŠã ã®äžçš®ã§ãæ¯ç©Žãç®æºã«èç©ããäœåãªéé
žåè質ãåžçããäœçšããããèèã鲿¢ããå¹ãåºç©äºé²ãæåŸ
ãããŸãã
ãŸããèèãã®åå ãæŽ»æ§åãããŠããŸãé
µçŽ ãŠããããŒãŒãåžçããäœçšãããå€å質ã®ç©è³ªãã·ãªã«ãé
åããŠããŸãã
â èãžã®ãããããšãã£ãŒãã¯ã¬ã³ãžã³ã°åãäž¡ç«ã
ãã¯ã¿ãŒãã«ãã®ãªãã¡ã€ãã³ã° ã¯ã¬ã€ããã¯ã¯èãžã®ãããããšãã£ãŒãã¯ã¬ã³ãžã³ã°åãäž¡ç«ãããªã±ãŒããªãŸã¶ããåã«ãOKïŒå
šé¡ã»å
šèº«ã«äœ¿ããŸãã
ãªããããªäœ¿ãå¿å°ãæŽãäžããã®ãã«ã¹ãæããæ¥œãã¿ããã ããªãããã¯ã³ããŒã³æããèãžâª

ã1ã ãã©ãŒã¬ã³
ãã¿ãã³ïŒ£ã®çŽ170åïŒ
ãã©ãŒã¬ã³ã®éå
åã§
æ¯ç©ŽãŸã§ãã¬ã€
ãã¿ãã³Cã®çŽ250åãã®é«ãéå
åãæã€ãã©ãŒã¬ã³ã§æ¯ç©Žã®é»ãã¿ïŒâ»1ïŒäºé²ã ã¯ã¬ã€ã®åžçåãšã®ããã«äœçšã§ããéææããµããèãžã
ïŒâ»1ïŒæ±ããå€ãè§è³ªã«ãã
ãã€ã€ã¢ã³ããšåãççŽ ååã®éåäœã§ããµãã«ãŒããŒã«ã®ãããªæ§é ãæã£ãŠããŸãããã¿ãã³Cã®çŽ170åãã®éå
åãæã¡ãçŸèãµãâããç®èã±ã¢ãããªã±ã¢ãä¿æ¹¿ã±ã¢ãªã©ãããŸããŸãªçŸå®¹å¹æãæåŸ
ã§ããŸãã
ã2ãã¢ãŒããã§ãŒã¯èãšãã¹
æ¯ç©ŽïŒçŽ«å€ç·ããã¬ãã
ã¹ããŒããã©ã³ãªã©ã®
ãã«ãŒã©ã€ã察çã«ã
æ¯ç©Žã±ã¢ã«æåŸ
ããããã¯ç§ãã§ãŠã»ã³ã¢ã¶ãããåŸããããšãã¹ãNF-kBïŒãšããšãã«ãããŒããŒïŒãæããŠãè²çŽ æ²çãå
èåã®äºé²ã«ã¢ãããŒãããæåãšèšãããŠããŸãã
ã3ããã ã¹ãšãã¹ïŒãã«ãé
žïŒ
ãã¿ãã³ãããã©ã«ãé
µçŽ ã
ã¢ããé
žãè±å¯ã«å«ãã 倪å€ã®æµã¿ã
倪å€ã®æ€ç©ãæµ·æŽæ§çç©ãªã©ãçšæãã“è
æ€å”(æ 逿åïŒããæœåºããããšãã¹ãé·ã幎æããããŠåŸ®çç©ã«ããåè§£ã»çºé
µã»çæãç¹°ãè¿ãããŠãããææ©é
žã§ããããã«ãé
žãããã¿ãã³ãããã©ã«ãé
µçŽ ãã¢ããé
žãè±å¯ã«å«ãŸããé«ãççæŽ»æ§äœçšããããŸããèããªãããã«æŽããæ¯ç©Žãç®ç«ããªãããäœçšããããŸãã

ãïŒãããŠãæ ¹ãšãã¹
挢æ¹ã®ãããã¹ãç¶æ
ã«æ»ãããšããåœåž°ã®å¹èœãååã®ç±æ¥ã®ã»ãªç§ã®å€å¹Žèã ã·ãã®èŠãæ¹ã«ã¯ã¡ã©ããœãŒã ã®éå°ãªèç©ãšãã®ååžãé¢ä¿ããŠããŸãã幎霢ãšãšãã«ã¿ãŒã³ãªãŒããŒãåæ»ããå¯éããã¡ã©ãã³ã¯ç®ç«ã£ãŠèŠããŸãããããé·ãéæ¶ããªãã·ãã“å±
座ããžã”ãçã¿åºããŸããããŠãæ ¹ãšãã¹ã¯ãã®ã¡ã©ããœãŒã ã®æ§é ãåè§£ã忣ããŸãã
ãïŒãããŠã€ãšãã¹
ã¡ã©ãã³ãåã蟌ãã 衚ç®åºåºçްèã®åè§£ãä¿é²ããèæ·±éšã«æ»åšããã¡ã©ãã³ã®æåºãä¿é²ãã·ãã®æ¹åãæ·¡è²åãæåŸ
ãããŸãã
ãïŒããã¿ãã³Cèªå°äœïŒãªã³é
žã¢ã¹ã³ã«ãã«MgïŒ
å®å®æ§ã®è¯ããã¿ãã³Cèªå°äœã§ãããã·ããŒãŒæŽ»æ§é»å®³ãã¡ã©ãã³éå
ã«ããè²çŽ æ²çæå¶äœçšã玫å€ç·ããèãå®ããã³ã©ãŒã²ã³åæä¿é²äœçšããããŸãã
ãïŒãã¢ã«ããã³
ãã€ããããã³ã®ååæ§é ãäžéšå€åãããŠéçºãããçµç·¯ããããã€ããããã³èªå°äœãšãåŒã°ããŸããã¡ã©ãã³ãäœãããã·ããŒãŒã®æŽ»æ§åãé»å®³ããããšã§ãçŸçœäœçšãçºæ®ããæåã§ãã
ãïŒããã©ã»ã³ã¿ãšãã¹ïŒããªã³ãã©ã»ã³ã¿ïŒ
ãµã±ç±æ¥ããã¢ã«ãã³é
žãã³ã©ãŒã²ã³ããšã©ã¹ãã³ãã³ã³ããã€ãã³ç¡«é
žãã¢ããé
žãªã©è±å¯ãªæ é€çŽ ãå«ã¿ãŸããç·ç¶èœçްè賊掻äœçšã®ä»ããã¡ãæŽããçŸçœäœçšãæåŸ
ãããŸãã
ãïŒãã«ã³ãŸãŠæ ¹ãšãã¹
ã«ã³ãŸãŠã®æ ¹åã¯æ ¹èããæœåºããŠåŸããããšãã¹ã倿°ã®ãã©ããã€ããå«ãŸããæççäœçšãäœçšãçŸçœäœçšããããŸãã
ãïŒã 倧æ°ã®æ±ããèã®ãã¡ãŒãžã«…
ã¢ã³ãããªã¥ãŒã·ã§ã³æåïŒâ»1ïŒïŒïŒ·ãã¢ã«ãã³é
žïŒé
å
è¿å¹Žåé¡ã«ãªã£ãŠããPM2.5ãã¯ãããææ°ã¬ã¹ããã°ãã®ç
ãè±ç²ãªã©ãç§ãã¡ã®æ¥åžžã¯ããŸããŸãªå€§æ°æ±æç©è³ªã«æãããŠããŸãã ãããã也ç¥ãããªäžè¶³ãããã¿ãªã©ã®ãèèåïŒâ»2ïŒããšå€§ããé¢ä¿ããŠããããšãè¿å¹Žæããã«ãªã£ãŠããŸããã ææ°ã¬ã¹ã®å€ãéœåžãšç©ºæ°ã綺éºãªèŸ²æã§æ¯èŒãããšãããéœåžéšã®èèåïŒâ»2ïŒãé²ãã§ãããšããçµæãå ±åãããŠããŸãã
1æ¥ã®çµããã®èã«ã¯ãæ±ãç®èãã¡ã€ã¯æ±ãã®ã»ããå€§æ°æ±æç©è³ªãä»çããŠããããããã£ããæŽãæµããªããŠã¯ãªããŸããã ãããªçŸä»£ã®èåé¡ã«ããããããã®ããã¯ã¬ã€ããã¯ã«ãããã£ãŒãã¯ã¬ã³ãžã³ã°ã ã¯ã¬ã€ã®åžçåã§æ®æ®µã®æŽé¡ã§ã¯åããããªãæ¯ç©Žãã·ã¯ã®å¥¥ã®æ±ããŸã§ãã£ããããã£ããæŽãæµããŠãŸã£ãããªçŽ èãžã
åæã«ã¢ã³ãããªã¥ãŒã·ã§ã³ïŒâ»1ïŒæåã®ïŒ·ïŒããã«ïŒãã¢ã«ãã³é
žãæŽãæµããåŸãèã«æ®ããããªã¢æ©èœããµããŒããå€ããã®åºæ¿ã«åŒ·ãèãžå°ããŸãã
ïŒâ»1ïŒã¢ã³ã(anti)ã¯ãåããããããªã¥ãŒã·ã§ã³(pollution)ã¯ãæ±æãã®æå³ãå€§æ°æ±æããèãå®ããã¢ã³ãããªã¥ãŒã·ã§ã³ãæåé
åã®åç²§åãè¿å¹Žå¢ããŠããŠããŸãã
ïŒâ»2ïŒèŠãç®ã®å°è±¡

â»ãã€ãéœåžéšãšéå€ã«äœã女æ§400人ã察象ã«èª¿æ»ãããšããã1æ¥ã«1äžå°ä»¥äžã®è»äž¡ãéãå¹¹ç·éè·¯ãã100m以å ã®ãšãªã¢ã®äººã¯ãé¡ã§35ïŒ ãé ¬ã§15ïŒ ãã·ããå€ããã»ãããç·ã4ïŒ å€ãåºãŸããã ïŒåºå žïŒ Journal of Investigative Dermatology 130, 2719-2726, 2010ïŒ

ãïŒããæ°Žã®éãéããããããŠãµã£ããããªè…å·¡ããµããŒãæå
ã¢ããã£ã
ã«èãšãã¹é
å
è§è³ªå
ã«ã¯ãæ°Žåã®éãéããšåŒã°ããå ŽæããããŸãããããå¢ãããŠæ°Žã®å·¡ããæçšæåã®æµžéãé«ããã®ã¯å€§åãªããšã§ãããªãã¡ã€ãã³ã° ã¯ã¬ã€ããã¯ã«ã¯ãæ°Žã®éãéããµããŒããããã¢ããã£ã
ã«èãšãã¹ããé
åãããŒã¿ãé²ãããã¡ãæŽããŠãµã£ããããªèãžå°ããŸãã
ãïŒãå£ç¯ãç°å¢ã®å€åã«ããèã®ãããã«…
氎溶æ§ããããªã°ãªã«ã³é
å
ãã¢ã«ãã³é
žã®çŽ1.3åã®è²¯æ°Žåãæã¡ãEGFïŒâ»3ïŒæ§äœçšãããããããªã°ãªã«ã³ã®é«ä¿æ¹¿ã±ã¢ã§ã å£ç¯å€åãç°å¢ã«åœ±é¿ãåããªããã©ãã«ã«åŒ·ãèãç®æããŸãã ïŒâ»3ïŒ ãEpidermal Growth Factorãã®ç¥ç§°ã§ãèã®è¡šé¢éšã§ã®æé·ã®å åã®ããš
ïŒâ»3ïŒ ãEpidermal Growth Factorãã®ç¥ç§°ã§ãèã®è¡šé¢éšã§ã®æé·ã®å åã®ããš

ïœããã¡ã§ç°¡åã»ã«ããšã¹ãïŒããªã€ãUPãããµãŒãžãžã§ã«ïœ
ã»ã©è¯ã匟åæãšãªããããªæãã¹ããå¯çæãå¿å°ãããããµãŒãžãžã§ã«ã
ïŒïŒŠâ»ïŒå€©ç¶ä¿æ¹¿æåïŒããã¢ã«ãã³é
žïŒä¿æ¹¿æåïŒãèã«ããªãããããããããŸãã
ãããµãŒãžå¹æã§è¡è¡ãä¿ããã¯ãã¢ããã±ã€ãœãŠæå®ãšãã¹ããã§ãŠãžãšãã¹çã®æ€ç©æŽèæåãèã«ããªãšåŒŸåãäžãããã£ãããšãããã§ã€ã¹ã©ã€ã³ãšèŒãããµããèã«å°ããŸãã
â»PCA-Naãä¹³é
žNa
ãŸãå¥åº·ãªçŽ èã®ç¶æã«å¿
èŠãªè§è³ªå±€ã®âªããªã¢æ©èœâ«ãé«ãããããŠã»ã³ã«ãºã©ãšãã¹ãããšããŠã ãã©ã³ã¿ã®ããŠã çš®åæ²¹ããé
åã
ãUSPTè€å掻æ§ãšãã¹ãããã¢ã«ãã³é
žããæµ·èãšãã¹ããNMFïŒå€©ç¶ä¿æ¹¿æåïŒããããããªã€ã«ããªã©ããããµãŒãžå¹æããµããŒãããçŸèæåãèŽ
æ²¢ã«é
åã
ãäœ¿çšæ¹æ³
âæŽé¡åŸãè»œãæ°ŽåãæãåãããããããŒå€§ãããã®éãé¡å
šäœã«ã®ã°ããŸãã
âïŒãïŒåçšåºŠããããããããµãŒãžããåŸãã¬ããŸæ¹¯ãŸãã¯æ°Žã§æŽãæµããŸããæ±ºããŠåãå
¥ããããªãããã«æ³šæããŸãããã
⌠ãå°é¡ãããµãŒãžãæ¹æ³ã玹ä»åç»ïŒ5å15ç§ïŒâ»BGM鳿¥œå ¥ã
âç¹é·æåã»å
šé
åæå
ã»ããŠã»ã³ã«ãºã©ãšãã¹
ã»ãšããŠã ãã©ã³ã¿ã®ããŠã çš®åæ²¹
ã»æµ·è»ãšãã¹
ã»ãã¢ã«ãã³é
ž
ã»ããããªã€ã«
ã»ã¯ãã¢ããã±ã€ãœãŠæå®ãšãã¹
ã»ãã¿ãã³ïŒ¥
ã»ãã§ãŠãžãšãã¹
ã»ãŽãŒã«ãã³ã«ã¢ããŒã«ãšãã¹
å šé åæå
æ°Žãã°ãªã»ãªã³ãBGãããªãšãã«ãããµãã€ã³ããžãã§ãã«ãžã¡ãã³ã³ãã¯ãã¢ããã±ã€ãœãŠæå®ãšãã¹ããã§ãŠãžãšãã¹ãã¯ãªãµã³ãã«ã ã€ã³ãžã¯ã ãšãã¹ããã³ãã§ããŒã«ããããçš®åæ²¹ããšããŠã ãã©ã³ã¿ã®ããŠã çš®åæ²¹ããã³ãžã³æ ¹ãšãã¹ãããŠãæ ¹ãšãã¹ãã·ã£ã¯ã€ã¯æ ¹ãšãã¹ããã°ã¯æ ¹ç®ãšãã¹ãã¯ã©ã©æ ¹ãšãã¹ãã¯ã¬ã¢ã³ãŠãšãã¹ããã€ãã©æå®ãšãã¹ãã¢ããšãã©èãšãã¹ãã°ãªãã«ãªãã³é ž2Kãã«ã³ãŸãŠæ ¹ãšãã¹ãã¢ã«ã®ã³é žNaãããŠã»ã³ã«ãºã©è±/è/ã€ããšãã¹ãPCA-Naãä¹³é žNaããã¢ã«ãã³é žNaãããã¯ãªçš®åæ²¹äžããåç©ããã¿ã€ã³ãã©ãŠãã€ã«ã°ã«ã¿ãã³é žãž(ãªã¯ãã«ããã·ã«/ãã£ãã¹ããªã«/ãããã«)ããªã¯ãã«ããã«ããŒã«ãããªã¹ãã³é žããªã°ãªã»ãªã«-10ãã«ã«ãããŒãæ°Žé žåNaãã¡ãã«ãã©ãã³